Navigation Links
Hologic to Preside Over NASDAQ Opening Bell Ceremony Marking the Start of Breast Cancer Awareness Month
Date:9/21/2011

BEDFORD, Mass., Sept. 21, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that Rob Cascella, Hologic's President and Chief Executive Officer, will preside over The NASDAQ Stock Market Opening Bell Ceremony marking the start of Breast Cancer Awareness Month. The ceremony will begin at 9:15 a.m. (ET) on October 3, 2011.

Breast cancer statistics are staggering:

  • One of eight U.S. women will get breast cancer in her lifetime.(i)
  • Breast cancer is the second leading cause of cancer death in the U.S. It is the leading cause of death in women aged 35 to 65 years.(ii)

    • But there is hope…

  • Between 1990 and 2007, the mortality rate from breast cancer in the United States decreased by 31 percent, principally due to the contribution of mammographic screening and improved therapies.(iii)
  • Approximately 2.5 million women with a history of breast cancer living in America are alive today.(iv)

    • Mr. Cascella will speak to the importance of empowering women to make their health a priority. "Early and accurate diagnosis of breast cancer is crucial to improving the outcome of women afflicted with this terrible, yet treatable, disease," Mr. Cascella notes. "We take our role as the leader in breast health very seriously and are excited to now be able to offer women 3D breast tomosynthesis for breast cancer screening and diagnosis. We are confident this new technology will help clinicians in catching breast cancers earlier and in significantly reducing the number of unnecessary diagnostic work-ups."

    In February, 2011, Hologic was the first company to obtain U.S. Food and Drug Administration (FDA) approval for
    '/>"/>

    SOURCE Hologic, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4

    Related medicine technology :

    1. Hologic Launches Automated Cervical Cancer Screening Solutions at IPV Meeting in Berlin
    2. Hologic Announces Third Quarter Fiscal 2011 Operating Results
    3. Hologic to Participate in Four Investor Conferences
    4. Hologic to Release Third Quarter Fiscal 2011 Operating Results on Monday, August 1, 2011
    5. Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China
    6. Hologic Features New Minimally Invasive Technologies at the American Congress of Obstetricians and Gynecologists Annual Meeting
    7. Hologic Announces Second Quarter Fiscal 2011 Operating Results
    8. Hologic to Release Second Quarter Fiscal 2011 Operating Results on Monday, May 2, 2011
    9. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
    10. High Rates of Pathological Complete Response in Patients with Advanced Esophageal Cancer in OPAXIO™ Phase II Study Reported in American Journal of Clinical Oncology
    11. Hologic Targets Womens Health Professionals at ECR 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/24/2013)... 24, 2013 The potential of ... delivery of therapeutic agents has been receiving undeniable attention ... showing significant promise. The crucial formulation considerations for orally ... play a major role in the efficiency of pulmonary ... development of new formulation techniques and devices in recent ...
    (Date:5/23/2013)... y PARÍS, 24 de mayo de ... ), un destacado desarrollador y fabricante de herramientas ... la diagnosis y tratamiento de la enfermedad vascular ... del ensayo ADVISE ( Ad enosine V ... E valuation) II durante la sesión de ensayo ...
    (Date:5/23/2013)... , May 23, 2013 Nephros, Inc. (OTC ... medical device company that develops and sells high performance ... its rights offering.  In addition, the concurrent temporary reduction ... expired on May 17, 2013. Nephros estimates ... from the rights offering.   A portion of the proceeds ...
    Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
    ... SILVER SPRING, Md., May 9, 2011 /PRNewswire-USNewswire/ – CoMeD ... a Republican State Senator filed an amendment to regulate ... made it illegal to buy, sell, manufacture, deliver, import, ... 0.3 micrograms of organic or inorganic mercury per milliliter ...
    ... May 9, 2011 TriReme Medical, Inc. (TriReme), a ... treatment of complex vascular disease, announced today the appointment ... their Board of Directors. Mr. Bose, Founder ... Singapore and was until recently Company Group Chairman at ...
    Cached Medicine Technology:Florida Legislature Refuses to Limit Mercury in Vaccines 2Florida Legislature Refuses to Limit Mercury in Vaccines 3TriReme Medical Lines Up Asian Strategy With Key Appointment of New Board Members 2
    (Date:5/24/2013)... of five medical students have an unconscious bias against ... authors, from Wake Forest Baptist Medical Center, noted the ... of obesity. They concluded that teaching medical students to ... the millions of Americans who are overweight or obese. ... relationship, and even a patient,s willingness or desire to ...
    (Date:5/24/2013)... fractional flow reserve (FFR) using pressure wire assessment ... leads to significant changes in the management of ... a study reported at EuroPCR 2013. , The ... strategy at coronary angiography for diagnosis of chest ... assessment of FFR in all the main coronary ...
    (Date:5/24/2013)... Transcatheter aortic valve implantation (TAVI) is effective and safe ... first results from a multicentre Asian registry reported at ... become a treatment option for selected patients with symptomatic ... from North American or European centres," Paul Chiam, senior ... the conference. He explained that it is unknown whether ...
    (Date:5/24/2013)... A new discovery at Oregon Health & Science University ... reacts when infected with the highly evasive HIV virus ... been utilizing this unique approach to develop its own ... results in animal studies. This latest research finding will ... the journal Science . , "A major ...
    (Date:5/24/2013)... 24, 2013 The producers of Health ... for Charlotte, North Carolina. It is one of the largest ... companies. The city is populated with more than a million ... residents in both North and South Carolina. Viewers who are ... can tune into WAXN-TV 64 Eyewitness News during the month ...
    Breaking Medicine News(10 mins):Health News:Many Medical Students Have Anti-Fat Bias, Study Finds 2Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:Registry confirms TAVI efficacy and safety in Asian patients 2Health News:OHSU research highlights promising strategy to help vaccines outsmart HIV 2Health News:Health Briefs TV Presents May Air Dates for Charlotte, North Carolina 2
    ... rankings aim to help families choose best option , , ... Medicare and Medicaid Services unveiled an updated Web site ... for elderly Americans and their families. , The updated ... similar to that used for hotels and motels, to ...
    ... NY, December 18, 2008Medical acupuncture, which is acupuncture performed ... school, is being used increasingly for pain control. Richard ... , a peer-reviewed journal ( www.liebertpub.com/acu ) and the ... is at the forefront of these efforts in the ...
    ... the European Association of Urology (EAU) will be held from ... (SE). The scientific programme covers the whole range of the ... it will all be discussed at the congress. ... are extended to a full-day event called EAU International Day ...
    ... study,s design may be to blame for desmoteplase,s poor showing, ... experimental clot-busting drug derived from the saliva of the vampire ... trial. , But hope for the drug, called desmoteplase, remains ... large enough to provide clear results. , "The sample size ...
    ... who suffer from thinning hair and hair loss with an all-natural ... all-natural DHT blockers with no side effects. , ... ... offering patients who suffer from thinning hair and hair loss with ...
    ... drug eluting stents (DES) stents coated with medication to ... angioplasty had better outcomes one year later than patients with ... published in CMAJ http://www.cmaj.ca/press/080050.pdf . , Mortality ... stents was significantly lower than for those with bare metal ...
    Cached Medicine News:Health News:Government Launches Nursing Home Rating System 2Health News:Government Launches Nursing Home Rating System 3Health News:Annual Congress European Association of Urology: highlights in Stockholm 2Health News:Bat Saliva-Based Stroke Drug Disappoints in Trial 2Health News:Bat Saliva-Based Stroke Drug Disappoints in Trial 3Health News:Your Chemist Shop Offers Patients a Revolutionary Alternative to Other Hair Loss Treatments for Both Men and Women 2
    The 7700 Reciprocating Saw completes the large power system with our simple twist-lock blade hub and selection of saw blades....
    The 7500 Drill/Reamer operates at two speeds for multiple applications, which is automatically controlled by the 16 different coupler attachments. The drill reamer can be used for, but is not limited...
    ... SmartDriver System consists of a pistol-grip handpiece ... with a wide range of couplers that ... orthopedic surgical applications., ,The Battery SmartDriver ... compared to the original Battery SmartDriver. The ...
    ... Meniscus Implant (CMI) is a type I ... irreparable meniscus tear or loss of meniscus ... procedure. The purpose of the CMI ... and return to a more vigorous lifestyle, ...
    Medicine Products: